Clinical Trial Update: Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the kinetics of HIV-RNA decay in seminal plasma of men treated with dolutegravir at the time of primary HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | Conditions: HIV Infection Primary | Phase 3 | Status: COMPLETED